HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshiaki Takahashi Selected Research

Miyoshi myopathy

4/2013Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B.
1/2012[A case of dysferlinopathy asymptomatic for 10 years after an episode of transient muscle weakness].
1/2010Rapid screening for Japanese dysferlinopathy by fluorescent primer extension.
11/2005[Mutational and clinical features of Japanese patients with dysferlinopathy (Miyoshi myopathy and limb girdle muscular dystrophy type 2B)].
10/2004[A patient with distal muscular dystrophy without mutations in dysferlin gene but with abnormal dysferlin localization in muscle fibers].
5/2004Novel dysferlin mutations and characteristic muscle atrophy in late-onset Miyoshi myopathy.
12/2002Miyoshi myopathy patients with novel 5' splicing donor site mutations showed different dysferlin immunostaining at the sarcolemma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshiaki Takahashi Research Topics

Disease

153Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2023 - 02/2007
116Neoplasms (Cancer)
05/2024 - 05/2003
33Lung Neoplasms (Lung Cancer)
06/2023 - 09/2004
28Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2024 - 08/2007
28Congenital Diaphragmatic Hernias
02/2021 - 08/2014
25Neoplasm Metastasis (Metastasis)
04/2024 - 01/2010
19Disease Progression
12/2023 - 12/2002
15Adenocarcinoma of Lung
02/2023 - 01/2011
14Hypoxia (Hypoxemia)
01/2017 - 08/2010
12Interstitial Lung Diseases (Interstitial Lung Disease)
03/2021 - 08/2009
12Adenocarcinoma
12/2020 - 02/2007
11Neutropenia
12/2020 - 03/2014
9Wounds and Injuries (Trauma)
08/2023 - 12/2006
8Febrile Neutropenia
12/2023 - 01/2016
7Diarrhea
11/2023 - 08/2009
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2022 - 12/2009
7Dysferlinopathy
01/2020 - 05/2005
7Thymoma (Thymic Carcinoma)
01/2017 - 12/2009
7Miyoshi myopathy
04/2013 - 12/2002
6Cachexia
05/2024 - 11/2017
6Carcinoma (Carcinomatosis)
01/2024 - 04/2010
6Pneumonia (Pneumonitis)
04/2022 - 08/2016
6Anorexia
07/2021 - 08/2009
6Osteosarcoma (Osteogenic Sarcoma)
09/2004 - 10/2003
5Nausea
11/2023 - 11/2010
5Pain (Aches)
07/2023 - 10/2004
5Malignant Mesothelioma
09/2019 - 03/2010
5Thrombocytopenia (Thrombopenia)
01/2017 - 11/2009
4Infections
04/2024 - 05/2014
4Inflammation (Inflammations)
05/2023 - 09/2018
4Muscular Dystrophies (Muscular Dystrophy)
01/2022 - 11/2004
4Breast Neoplasms (Breast Cancer)
09/2018 - 03/2011
4Vascular Remodeling
02/2018 - 05/2015
4Pulmonary Hypertension
02/2017 - 01/2011
4Muscular Diseases (Myopathy)
12/2015 - 12/2005
3Colorectal Neoplasms (Colorectal Cancer)
05/2024 - 09/2011
3Body Weight (Weight, Body)
05/2024 - 02/2021

Drug/Important Bio-Agent (IBA)

61ErbB Receptors (EGF Receptor)IBA
12/2023 - 11/2008
33Tyrosine Kinase InhibitorsIBA
01/2023 - 11/2008
29PlatinumIBA
12/2023 - 08/2007
26Cisplatin (Platino)FDA LinkGeneric
12/2023 - 03/2009
26nitrofenIBA
02/2021 - 08/2014
22Biomarkers (Surrogate Marker)IBA
06/2023 - 02/2011
22Gefitinib (Iressa)FDA Link
01/2023 - 02/2007
21Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2014 - 11/2009
17osimertinibIBA
12/2023 - 01/2017
15DysferlinIBA
01/2020 - 12/2002
14Immune Checkpoint InhibitorsIBA
01/2024 - 01/2016
14Carboplatin (JM8)FDA LinkGeneric
01/2023 - 02/2007
13B7-H1 AntigenIBA
02/2023 - 12/2018
12Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2023 - 02/2007
12Docetaxel (Taxotere)FDA Link
09/2019 - 02/2007
11Glucose (Dextrose)FDA LinkGeneric
05/2024 - 08/2010
11Vinorelbine (Navelbine)FDA LinkGeneric
12/2023 - 03/2009
11Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
02/2014 - 08/2010
10Pemetrexed (MTA)FDA Link
12/2023 - 03/2010
10NivolumabIBA
01/2021 - 01/2016
9Proteins (Proteins, Gene)FDA Link
11/2023 - 04/2009
9Etoposide (VP 16)FDA LinkGeneric
01/2023 - 06/2010
9pembrolizumabIBA
01/2022 - 03/2019
8HexokinaseIBA
02/2014 - 01/2011
7Irinotecan (Camptosar)FDA LinkGeneric
01/2022 - 09/2004
7Deoxyglucose (2 Deoxy D glucose)IBA
02/2014 - 08/2010
6amrubicinIBA
12/2023 - 08/2007
6durvalumabIBA
04/2022 - 10/2020
6Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 02/2007
6Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
03/2014 - 05/2011
5ParaffinIBA
04/2024 - 04/2014
5Thymidylate SynthaseIBA
01/2014 - 09/2011
5TOR Serine-Threonine KinasesIBA
10/2013 - 01/2011
4EnzymesIBA
11/2023 - 08/2004
4Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2023 - 12/2009
4Formaldehyde (Formol)FDA Link
01/2021 - 04/2014
4Anaplastic Lymphoma KinaseIBA
10/2020 - 07/2015
4GemcitabineFDA Link
06/2019 - 10/2009
4CrizotinibIBA
10/2018 - 09/2013
4Bevacizumab (Avastin)FDA Link
11/2016 - 06/2013
4Orotate PhosphoribosyltransferaseIBA
01/2014 - 09/2011
4Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
01/2014 - 09/2011
4Hydroxyl RadicalIBA
09/2004 - 10/2003
4Free RadicalsIBA
09/2004 - 10/2003
4Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
09/2004 - 10/2003
3sotorasibIBA
11/2023 - 01/2021
3LigandsIBA
01/2023 - 03/2019
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2013
3Therapeutic UsesIBA
01/2022 - 11/2011
3130-nm albumin-bound paclitaxelIBA
01/2022 - 03/2019
3Creatine Kinase (Creatine Phosphokinase)IBA
01/2022 - 05/2004

Therapy/Procedure

82Drug Therapy (Chemotherapy)
01/2024 - 02/2007
66Therapeutics
01/2024 - 05/2005
32Radiotherapy
04/2024 - 05/2003
20Chemoradiotherapy
01/2022 - 12/2009
12Adjuvant Chemotherapy
12/2023 - 03/2009
9Aftercare (After-Treatment)
11/2021 - 05/2011
7Catheters
04/2024 - 12/2015
5Activities of Daily Living (ADL)
10/2023 - 03/2005
4Appendectomy
12/2019 - 09/2010
4Combination Drug Therapy (Combination Chemotherapy)
01/2019 - 01/2013
4Cranial Irradiation
04/2018 - 01/2017
3Immunotherapy
01/2022 - 01/2021